BackEuropean Biotech Acquisition - Warrants (06/03/2026) Overview

European Biotech Acquisition - Warrants (06/03/2026) EBIT

EBIT (Earnings Before Interest and Taxes) analysis for EBACW.

Quarterly EBIT

-$1.17M
115.38% YoY

As of Dec 31, 2022

Annual EBIT (TTM)

-$2.82M
156.21% YoY

Trailing 12 months ending Dec 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)